STD Diagnostics Market By Disease Type (Bacterial STDs {Chlamydia, Gonorrhea, Syphilis, Others}, Viral STDs {Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), Herpes Simplex Virus (HSV-1 & HSV-2), Hepatitis B & C, Others}, Parasitic & Fungal STDs {Trichomoniasis, Candidiasis, Others}), By Test Type (Laboratory-Based Testing {Nucleic Acid Amplification Tests (NAATs), Polymerase Chain Reaction (PCR), ELISA (Enzyme-Linked Immunosorbent Assay), Immunoassays, Western Blot, Others}, Point-of-Care (POC) Testing {Rapid Diagnostic Tests (RDTs), Lateral Flow Assays, Home Testing Kits}), By Technology (Molecular Diagnostics, Immunoassays, Microscopy, Chromatography, Others), By Sample Type (Blood, Urine, Swab Samples, Saliva, Others), By End User (Hospitals, Diagnostic Laboratories, Specialty Clinics, Self-Testing, Public Health Agencies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & Forecast Parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. STD Diagnostics Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Increasing prevalence of sexually transmitted diseases worldwide.

3.2.2. Growing government initiatives promoting sexual health and prevention.

3.2.3. High demand for rapid and home-based STD diagnostic tests.

3.3. Key industry pitfalls & challenges

3.3.1. Lack of awareness about available STD diagnostic services.

3.3.2. Stigma surrounding sexual health testing hindering public participation.

3.3.3. Lack of trained professionals for accurate STD diagnosis.

3.4. Market Opportunities

3.4.1. Expanding telemedicine services for remote STD diagnostic consultations.

3.4.2. Growing demand for point-of-care diagnostic devices globally.

3.4.3. Technological advancements in AI for enhanced diagnostic capabilities.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. STD Diagnostics Market, Disease Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Disease Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Bacterial STDs

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.2. Chlamydia

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.3. Gonorrhea

4.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.4. Syphilis

4.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.5. Others

4.3. Viral STDs

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.2. Human Immunodeficiency Virus (HIV)

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.3. Human Papillomavirus (HPV)

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.4. Herpes Simplex Virus (HSV-1 & HSV-2)

4.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.5. Hepatitis B & C

4.3.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.6. Others

4.3.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Parasitic & Fungal STDs

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.2. Trichomoniasis

4.4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.3. Candidiasis

4.4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.4. Others

4.4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. STD Diagnostics Market, Test Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Test Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Laboratory-Based Testing

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.2. Nucleic Acid Amplification Tests (NAATs)

5.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.3. Polymerase Chain Reaction (PCR)

5.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.4. ELISA (Enzyme-Linked Immunosorbent Assay)

5.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.5. Immunoassays

5.2.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.6. Western Blot

5.2.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.7. Others

5.2.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Point-of-Care (POC) Testing

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3.2. Rapid Diagnostic Tests (RDTs)

5.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3.3. Lateral Flow Assays

5.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3.4. Home Testing Kits

5.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. STD Diagnostics Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Molecular Diagnostics

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Immunoassays

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Microscopy

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Chromatography

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Others

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. STD Diagnostics Market, Sample Type Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Sample Type, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Blood

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Urine

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Swab Samples

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Saliva

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.6. Others

7.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. STD Diagnostics Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Diagnostic Laboratories

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Specialty Clinics

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Self-Testing

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.6. Public Health Agencies

8.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. STD Diagnostics Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Disease Type, 2025-2035

9.2.3. North America Market Revenue, By Test Type, 2025-2035

9.2.4. North America Market Revenue, By Technology, 2025-2035

9.2.5. North America Market Revenue, By Sample Type, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Disease Type, 2025-2035

9.2.7.2. U.S. Market Revenue, By Test Type, 2025-2035

9.2.7.3. U.S. Market Revenue, By Technology, 2025-2035

9.2.7.4. U.S. Market Revenue, By Sample Type, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Disease Type, 2025-2035

9.2.8.2. Canada Market Revenue, By Test Type, 2025-2035

9.2.8.3. Canada Market Revenue, By Technology, 2025-2035

9.2.8.4. Canada Market Revenue, By Sample Type, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Disease Type, 2025-2035

9.3.3. Europe Market Revenue, By Test Type, 2025-2035

9.3.4. Europe Market Revenue, By Technology, 2025-2035

9.3.5. Europe Market Revenue, By Sample Type, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Disease Type, 2025-2035

9.3.7.2. Germany Market Revenue, By Test Type, 2025-2035

9.3.7.3. Germany Market Revenue, By Technology, 2025-2035

9.3.7.4. Germany Market Revenue, By Sample Type, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Disease Type, 2025-2035

9.3.8.2. France Market Revenue, By Test Type, 2025-2035

9.3.8.3. France Market Revenue, By Technology, 2025-2035

9.3.8.4. France Market Revenue, By Sample Type, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Disease Type, 2025-2035

9.3.9.2. U.K. Market Revenue, By Test Type, 2025-2035

9.3.9.3. U.K. Market Revenue, By Technology, 2025-2035

9.3.9.4. U.K. Market Revenue, By Sample Type, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Disease Type, 2025-2035

9.3.10.2. Italy Market Revenue, By Test Type, 2025-2035

9.3.10.3. Italy Market Revenue, By Technology, 2025-2035

9.3.10.4. Italy Market Revenue, By Sample Type, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Disease Type, 2025-2035

9.3.11.2. Spain Market Revenue, By Test Type, 2025-2035

9.3.11.3. Spain Market Revenue, By Technology, 2025-2035

9.3.11.4. Spain Market Revenue, By Sample Type, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Disease Type, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Test Type, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Technology, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Sample Type, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Disease Type, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Test Type, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Sample Type, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Disease Type, 2025-2035

9.4.7.2. China Market Revenue, By Test Type, 2025-2035

9.4.7.3. China Market Revenue, By Technology, 2025-2035

9.4.7.4. China Market Revenue, By Sample Type, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Disease Type, 2025-2035

9.4.8.2. Japan Market Revenue, By Test Type, 2025-2035

9.4.8.3. Japan Market Revenue, By Technology, 2025-2035

9.4.8.4. Japan Market Revenue, By Sample Type, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Disease Type, 2025-2035

9.4.9.2. India Market Revenue, By Test Type, 2025-2035

9.4.9.3. India Market Revenue, By Technology, 2025-2035

9.4.9.4. India Market Revenue, By Sample Type, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Disease Type, 2025-2035

9.4.10.2. Australia Market Revenue, By Test Type, 2025-2035

9.4.10.3. Australia Market Revenue, By Technology, 2025-2035

9.4.10.4. Australia Market Revenue, By Sample Type, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Disease Type, 2025-2035

9.4.11.2. South Korea Market Revenue, By Test Type, 2025-2035

9.4.11.3. South Korea Market Revenue, By Technology, 2025-2035

9.4.11.4. South Korea Market Revenue, By Sample Type, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Disease Type, 2025-2035

9.4.12.2. Singapore Market Revenue, By Test Type, 2025-2035

9.4.12.3. Singapore Market Revenue, By Technology, 2025-2035

9.4.12.4. Singapore Market Revenue, By Sample Type, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Disease Type, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Test Type, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Sample Type, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Disease Type, 2025-2035

9.5.3. Latin America Market Revenue, By Test Type, 2025-2035

9.5.4. Latin America Market Revenue, By Technology, 2025-2035

9.5.5. Latin America Market Revenue, By Sample Type, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Disease Type, 2025-2035

9.5.7.2. Brazil Market Revenue, By Test Type, 2025-2035

9.5.7.3. Brazil Market Revenue, By Technology, 2025-2035

9.5.7.4. Brazil Market Revenue, By Sample Type, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Disease Type, 2025-2035

9.5.8.2. Argentina Market Revenue, By Test Type, 2025-2035

9.5.8.3. Argentina Market Revenue, By Technology, 2025-2035

9.5.8.4. Argentina Market Revenue, By Sample Type, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Disease Type, 2025-2035

9.5.9.2. Mexico Market Revenue, By Test Type, 2025-2035

9.5.9.3. Mexico Market Revenue, By Technology, 2025-2035

9.5.9.4. Mexico Market Revenue, By Sample Type, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Disease Type, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Test Type, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Sample Type, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Disease Type, 2025-2035

9.6.3. MEA Market Revenue, By Test Type, 2025-2035

9.6.4. MEA Market Revenue, By Technology, 2025-2035

9.6.5. MEA Market Revenue, By Sample Type, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Disease Type, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Test Type, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Technology, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Sample Type, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Disease Type, 2025-2035

9.6.8.2. South Africa Market Revenue, By Test Type, 2025-2035

9.6.8.3. South Africa Market Revenue, By Technology, 2025-2035

9.6.8.4. South Africa Market Revenue, By Sample Type, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Disease Type, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Test Type, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Sample Type, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Abbott Laboratories

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. Thermo Fisher Scientific

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. BD (Becton, Dickinson and Company)

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Hologic, Inc.

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. Cepheid

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Roche Diagnostics

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. BioMérieux

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Grifols

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Siemens Healthineers

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. QIAGEN

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. AbbVie

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Orasure Technologies

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Merck & Co., Inc.

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Mylan

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. Alere

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis